| Name | Title | Contact Details |
|---|
WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as CX Industries Inc., a wholly-owned subsidiary which specializes in cannabis extraction from the Company`s fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed`s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD`s direct sales to medical patients. The Company maintains strategic relationships in the seniors` market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold. Our team of experienced growers, scientists and qualified professionals are committed to providing the best quality medicines and products to patients and consumers across Canada. WeedMD is listed on the TSX-V under the symbol WMD.
CareQuest Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Summus Global, the leading virtual specialist platform, empowers families by providing access to a network of 4,000+ top specialists across 48 leading hospitals -- within days, from anywhere in the world.
Pronger Smith Medical Care is a Tinley Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.